Growth opportunity Procaps is a mid to large-sized LatAm pharmaceutical manufacturer with a broad regional footprint and ongoing leadership changes, suggesting a potential need for scalable manufacturing, supply chain optimization, and governance-compliant financing solutions to support expansion.

Financial restructuring Recent equity investment and debt restructuring, plus a headquarters move to Bogotá, indicate a strategic growth push and potential demand for advisory services, working capital solutions, and export financing to accelerate capital deployment.

Delisting risk Nasdaq delisting and delinquency notices point to heightened diligence requirements and potential cost controls; opportunity to offer risk management, regulatory reporting services, and LoB compliance tools to maintain market credibility.

Tech enablement Adoption of Salesforce and analytics tools suggests openness to digital transformation; cross-sell enterprise software, automation, CRM optimization, and data analytics services to improve sales, forecasting, and regulatory reporting.

Sustainability & scale Growth-focused narrative and community health mission align with environmental, social, and governance (ESG) initiatives; positioning for sustainable supply chain improvements, quality systems upgrades, and patient-access programs to broaden market reach.